Cisplatin (cis-[Pt(NH3)2C121) is a widely used antitumor agent whose mutagenic activity raises the possibility of the induction of secondary cancer as a result of treatment. Mutation of the proto-oncogene H-ras is found in more than 30% of all human tumors, where it has been postulated to contribute to the initiation and progression of human cancers. Activating mutations in the H-ras gene are predominantly single-base substitutions, most frequently at codons 12, 13 and 61. In the present work we have studied the mutational spectra induced by a single cis-[Pt(NH3)2d(GpG)l adduct, the most frequent DNA crosslink formed by cisplatin. We have constructed a 25-mer-Pt oligonucleotide singly modified at codon 13 (GGT) within the human H-ras DNA sequence and we have inserted it into a single-stranded SV40-based shuttle vector able to replicate in simian COS7 cells. After replication in the mammalian host, vectors were extracted, amplified in bacteria and DNA from 124 randomly chosen colonies was sequenced. The observed mutation frequency was 21%. Base substitutions were the most frequent modification. 92% of the mutagenic events occurred at one or both of the platinated guanines of codon 13. The single G-T transversion accounted for 65% of the total mutations scored. All single base substitutions were located at the G in the 3' position showing, for the first time, that the guanine at the 3' side of a cis-fPt(NH3)2d(GpG)J adduct may be a preferential site for cisplatin induced mutations. The substitution G-T at this position of the codon 13 of the H-ras proto-oncogene is known to induce the oncogenic properties of the p21ras protein.
INTRODUCTION cis-Diamminedichloroplatinum(ll) (cisplatin or cis-DDP) is a drug
that is frequently used in cancer chemotherapy, mainly for the treatment of testicular and ovarian cancers (1) . The compound reacts covalently with DNA and intrastrand crosslinks are the most prevalent damages, in particular the cis-fPt(NH3)2d(GpG)j adduct which accounts for at least 50% of the total lesions (for reviewes 2, 3) . It has been shown that a lesion at the d(GpG) sequence can interfere with in vitro DNA replication and transcription (4) (5) (6) (7) (8) (9) (10) , and with DNA unwinding catalyzed by helicases (11) (12) (13) . Furthemore, this adduct seems to be poorly repaired by eukaryotic cellular extracts (14, 15) . It has been proposed that the cis-tPt(NH3)2d(GpG)J adduct is the main lesion responsible for the cytotoxicity of cisplatin (16) .
Cisplatin treatment may have several undesirable side effects, including tumorogenesis (which has been observed in both rats and mice) and mutagenesis (reported in both eukaryotic and prokaryotic cells) (17, 18 , for review 19) . In order to evaluate the risks for patients treated with this antitumor drug to develop secondary tumors and to avoid or to miniminize their impact, we need to understand the mechanism by which such complications develop. Studies of the spectrum of mutations induced by cis-DDP could contribute to this goal. Indeed, point mutations in specific genes, such as some proto-oncogenes or tumor supressor genes, are believed to be the initiating tumorogenic event. The majority of human cancers exhibit point mutations in the p53 tumor suppressor gene (20) and/or in specific codons of the ras gene family. The more mutagenic a drug is, the greater are its chances of producing secondary tumors.
The pattern of DNA mutations produced by cisplatin has been previously examined in prokaryotic and eukaryotic systems, such as in the lacI gene of Escherichia coli (21) , in the tetracycline resistance gene of E.coli (22) , in the Chinese hamster ovary adenine phosphoribosyl transferase gene (23) , in the yeast sup4-0 gene (24) , in the supF gene of a shuttle vector transfected into normal and XP human cells (25) , and in exon 3 of the endogenous human hypoxanthine guanine phosphoribosyl transferase gene (26) . In all these studies the DNA was randomly modified by cisplatin and the presence of several DNA lesions makes quantitative analysis of the mutation spectrum difficult. Base pair substitutions were mainly encountered, in particular at d(ApG) or d(GpG) sequences previously described as preferential sites *To whom correspondence should be addressed.
for cisplatin interactions. Some of these studies reported mutational hot spots (24-26) while others did not (22, 23) . Mutational spectra in E.coli have also been determined after infection by single-stranded DNA containing a specific cis-DDP DNA adduct, either cis-[Pt(NH3)2d(ApG)J or cis-tPt(NH3)2d(GpG)1 (27, 28) . It was found that mutagenic processing of the lesion requires induction of the SOS system; base pair substitutions were observed at the 5' side of the lesion, among which transversions AT-TA (27) and GC -TA (28) were the most prevalent. Bradley et al (28) have shown that in the singly platinated single-stranded vector the mutation frequency was 5 times higher than in the double-stranded vector. Since single-stranded DNA carrying cis-DDP lesion(s) cannot be processed by excision repair enzymes, a translesion synthesis must occur in order to produce fully replicated double-stranded vector. Such translesion synthesis is believed to be responsible for the observed base pair substitutions induced by the platination of both single-stranded and double-stranded DNA. In vivo point mutations resulting from the replication through a cisplatin bifunctional cross-link might lead to the activation of proto-oncogenes and therefore participate in the establishment of secondary cancer. Mutant ras genes have frequently been detected in tumors and tumor cells and activation of ras gene products are thought to be involved in tumor initiation and/or progression. In addition, activated ras gene may participate in the establisment of a resistant phenotype to cisplatin (29) (30) (31) . Base substitutions have been most frequently observed in mutation hot spots at codons 12, 13, 59 and 61 (32, 33) .
In this work we have examined the mutation spectra induced by a single cis-[Pt(NH3)2d(GpG)J adduct located at the sequence d(GGT) of the codon 13 of H-ras gene (34) . The modified DNA sequence was introduced into a single-stranded SV40-based shuttle vector which transiently replicates in simian COS7 cells (35) . We found that G-T transversion were the most commonly encountered mutations. All mutations were targeted at the lesion site and were preferentially located at the 3' side of the bifunctional adduct.
MATERIALS AND METHODS Cells and bacteria
Monkey COS7 cells were grown in 90 mm Petri dishes in Dulbecco's modified Eagle medium supplemented with 7% fetal calf serum in a 5 % CO2 humidified atmosphere. Mutant plasmids were isolated and selected using E.coli DH5a (recAI, hsdRl7(rK-, mK+)) bacteria on LB medium. JM 105 bacteria were used to produce single-stranded DNA.
Plasmid
The plasmid pS189, a generous gift from Dr.Seidman, has been described previously (36) . The replication origins of both SV40 and the miniplasmid P AN7 (ori P) allow replication of the vector in mammalian cells and in bacteria respectively. Selection of transformed bacteria is based upon the ampicillin resistance gene carried by the plasmid. M13 phage replication is active in this vector (37) and allows production of single-stranded plasmid DNA using the M13 KO7 helper phage as described in Analects (Pharmacia).
Oligonucleotide synthesis
The oligonucleotide 14-, 22- and 50-mers shown in Figure 1 , were synthesized on Cyclone Plus DNA synthesizer from MilliGen/Biosearch (Novato, CA) and purified as previously described (34 are located in the 62-mer scaffold, were performed. The same protocol was used to construct the unmodified vector.
Mutational assay Subconfluent COS7 cells were transfected, using the DEAE dextran method (39) , with the single-stranded plasmid DNA containing the partial H-ras sequence, either intact or carrying a cis-DDP adduct in the codon 13. Three days later cells were harvested and extrachromosomal DNA was extracted using an alkaline lysis procedure (40) . After digestion with the Bglll restriction endonuclease to eliminate any contaminant molecules which did not contain the 25-mer insert, the DNA was shuttled into E. coli DH5a bacteria by Hanahan's method (41) . Plasmid DNA was extracted from ampicillin resistant clones by an alkaline lysis method, and randomly chosen DNA molecules were then sequenced by the chain elongation terminating method using sequenase II kits (USB). (42) . Electrophoretic analysis of the purified platinated 25-merPt showed that its mobility was reduced when compared to the purified unplatinated 25-mer (Fig 3B) , thus confirming the presence of the adduct (43) . The 25-mers, either intact or platinated, were subsequently inserted into the single-stranded vector, as depicted in Fig 2 and (34) , we attempted to apply the same protocol to the 8-mer-Pt on the codon 12 of H-ras sequence. However, we were unable to obtain ligation at the 5' side of this 8-mer-Pt (data not shown). Our ability to ligate the platinated 8-mer-Pt containing the adduct on the codon 13, d(CCGGCG*G*T), but not the one bearing the lesion on the codon 12, d(CCG*G*CGGT), might be explained by the observation that the distorsion of the double helix is more pronounced at the 5' side of the bifunctionnal adduct than at the 3' side (43, 45, 46) which could lead to inefficient ligation at the 5' side of the 8-merPt at the codon 12.
RESULTS

Construction
The 25-mer oligonucleotides either intact or platinated, were inserted into the single-stranded vector as outlined in Fig 2. We have chosen a single-stranded vector so that removal of the lesion by a nucleotide excision repair mechanism prior its replication can not occur. To insure that only the circular single-stranded DNA ligation product depicted in Fig 2 will be amplified in the cell, we digested with restriction endonucleases the singlestranded/62-mer scaffold hybrid which could have escaped our purification protocol. The linear DNA, either produced by the endonucleases digestion or by a partial ligation of the 25-mer to the vector, will be rapidly degraded in the cell (Cabral-Neto, J.B., Gentil, A., Margot, A., and Sarasin, A., unpublished results).
Several laboratories have studied the replication, both in vivo and in vitro, of single-stranded DNA containing the specific cis-[Pt(NH3)2d(GpG)J lesion (7, 9, 10, 28, 47) . Two reports have examined the capacity of prokaryotic DNA polymerases to bypass the cis-DDP lesion in vitro. In the first, for all the enzymes tested (T7 pol, Taq pol, T4 pol, E. coli Klenow fragment and pol Ell holoenzyme) the authors found a translesion synthesis varying from 2% to 6% depending on the polymerase used (7). In the second, only the E. coli Klenow fragment showed the capacity to elongate past the lesion to an extent of 10% to 25%, while for the pol Ill holoenzyme or its a subunit, no bypass was observed (10) . No detectable bypass synthesis was observed in vitro with the eukaryotic E polymerase (9) . The survival rate of the (+) strand of the M 13 genome containing a unique d(GpG) adduct was approximatively 10% following its transfection into wild type E. coli (28, 47) . In the present study we estimate that the survival of the vector bearing the cis-fPt(NH3)2d(GpG)J adduct in COS7 cells was roughly of 26%, while the frequency of induced mutations was of 21 %. Survival was calculated by comparing the number of the ampicillin resistant E. coli colonies after transfection with total DNA recovered from COS7 cells transformed with either platinated or unplatinated vector. The high rate of survival detected here for platinated vectors could be attributed to a relatively efficient bypass of the lesion by the host replicative machinery. This substantial translesion synthesis resulted in an elevated rate of mutations.
The observed mutagenic events were highly targeted, since 92% of them were located on one or both of the guanines of the (GGT) triplet of codon 13 (Table 1) . Among the detected base changes, the transversion G -T accounted for 65 % of the total mutations. The appearance of this type of transversion is in agreement with the 'A rule', suggesting the preferential incorporation of a A in front of a non instructional lesion (48) . Previous studies in mammlian cells, aimed at determining the sites of mutations induced by cisplatin, indicated that mutations occured at the binding site of the drug, and that base pair substitutions were the most frequent mutations. However G-T was not always the major base substitutions observed (21) (22) (23) (24) (25) (26) (27) (28) .
One interesting feature of our results is the observation that the most frequent base substitutions were situated at the 3' side of the cis-[Pt(NH3)2d(GpG)j adduct (Table 1) . Since the vectors sequenced were randomly chosen from the total population, we think that the location of nearly all the mutations at the 3' side of the adduct was not the result of a selection bias. The 3' position of the mutations contrasts with previous reports in prokaryotic systems showing that specific d(ApG) and d(GpG) cis-DDP crosslinks provoked mutagenic events mainly at the 5' side of the lesions (27, 28) . These authors attributed the finding that the 5' platinated nucleotide acts as a primary misinformational site, to the observation that platinum distortion of the DNA helix is more pronounced at the 5' side of the lesion (43, 45, 46) . Cisplatin induced mutagenesis previously reported in eukaryotic systems was located at runs of purines in the DNA sequence, thus preventing a precise location of the mutagenic event either on the 3' or the 5' side of the putative adducts.
There are several possible explanations for the discrepancy between observed mutation sites in E. coli and our results. The fact that we found induced mutations almost exclusively at the 3' side of the cis-fPt(NH3)2d(GpG)J crosslink, shows that preferential mutation position is not determined only by the structure of the dinucleotide adduct. In the present study guanine residues are found in the nucleotide sequences adjacent to the cis-fPt(NH3)2d(GpG)J lesion, whereas the flanking sequences in previous studies with prokaryotes have fewer purines and lack guanine (27, 28) . The influence of sequence context on the site of preferential base substitution can not be demonstrated or ruled out by this limited data. Alternatively, different mutation hotspots at the platinated dinucleotide could reflect different processing of the lesion in prokaryotes and eukaryotes. The mutation at the 3' side of the cis-IPt(NH3)2d(GpG)J lesion observed here could be the consequence of fundamental differences in translesion synthesis by E.coli and eukaryotic replication machineries, stressing that caution may be necessary in extrapolating mutation profiles which have been determined in prokaryotes. The cis-DDP induced transversion G-T that we have observed at very high frequency at the codon 13 of H-ras gene will lead to a Gly-Val change in the oncogenic p21ral protein. This particular amino-acid substitution has been reported to be one of the key step in the activation of the proto-oncogene (32) . This activation is believed to be part of the process of tumorigenicity and could contribute to secondary tumor formation as a result of cisplatin treatment or to the acquisition of a cisplatin resistant phenotype (29) (30) (31) .
The biochemical mechanisms enabling DNA synthesis past the cis-[Pt(NH3)2d(GpG)J lesion are a current subject of investigation. A report examining in vitro replication of the Hras proto-oncogene by the eukaryotic polymerase a has recently been published (49) . Studies of in vitro DNA synthesis by eukaryotic proteins acting on templates containing the specific cis-fPt(NH3)2d(GpG)] crosslink on the codon 13 of H-ras protooncogene are underway in our laboratory and are expected to elucidate the molecular mechanisms of its activation.
